Filibuvir |
Katalog-Nr.GC36045 |
Filibuvir ist ein oral wirksamer, selektiver, nicht nukleosidischer Inhibitor der RNA-abhÄngigen RNA-Polymerase (RdRp) des HCV-Nichtstrukturproteins 5B (NS5B).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 877130-28-4
Sample solution is provided at 25 µL, 10mM.
Filibuvir is a potent, selective non-nucleoside inhibitor (NNI) of the HCV nonstructural 5B protein (NS5B) RNA-dependent RNA polymerase, and it binds noncovalently in the "Thumb 2" pocket of NS5B. In vitro, filibuvir is equipotent against genotype 1a and 1b replicons, with an EC50 of 59 nM[1].
[1]. Wagner F, et al. Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients. Hepatology. 2011 Jul;54(1):50-9.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *